Cart
0

World Melanoma Therapeutics Market - Opportunities and Forecasts, 2017-2023

Get 20% Free Customization In This Report
LI_181449
Pages: NA
Dec 2018 | 598 Views
 
Author's : NA
Tables: NA
Charts: NA
 

The global melanoma market has witnessed an unprecedented boost in market size, owing to a dynamically evolving nature of melanoma treatments over the past few years. The high demand of novel early stage and advanced melanoma therapies along with a booming patient base, has created an impending need for better therapies in the melanoma market. Although, a plethora of treatment options are available today, several immunotherapies and combination therapies are expected to enter the market. Large uptake of these novel treatments is expected due to their improved survival benefits and minimal side effects. Additionally, untapped patient population, especially, in the Europe and U.S. would lead to a higher uptake of novel treatments in the near future.

According to the skin cancer foundation, ~an estimated total of 73,870 new diagnosed cases of melanoma are expected in 2015. With an expected death toll of 9,940 cases, melanoma would account for the majority of skin cancer deaths in 2015.

A strong emerging pipeline, rising incidences of melanoma cases and the increasing public awareness are the major factors driving the melanoma market. In addition, the growing interest of physicians towards novel therapies would fuel the market. Conversely, high costs incurred due to combination treatments and limited reimbursement is likely to curtail the market growth.

For companies like Bristol Myers Squibb (BMS), apposite product positioning of novel treatments in order to avoid cannibalization of marketed products would be a key challenge to sustain in the melanoma market. However, untapped geographical regions, which include some parts of Europe and the Asia Pacific with a high undiagnosed patient population, would provide lucrative growth opportunities.

Few of the key strategies adopted by leading players in the market are new product launches and fast track approvals. Recently, Bristol Myers Squibb (BMS) received an FDA clearance for supplemental Biologics License Application (sBLA) of Opdivo. In late 2014, the Food and Drug Administration (FDA) granted a fast track approval for a drug called Keytruda, developed by Merck & Co.

To provide a comprehensive market assessment, the report segments the Melanoma Therapeutics market on the basis of therapy types and geography. Based on the therapy type, the market is segmented into Chemotherapy, Biologic therapy, Targeted therapy, Radiation therapy, Surgery and other novel therapies. In terms of melanoma stages, the market is segmented into Stage 0 (Melanoma in Situ), Stage I, Stage II, Stage III and Stage IV. The report covers a geographic breakdown and a detailed analysis of each of the aforesaid segments across North America, Europe, Asia Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Bristol-Myers Squibb (BMS), Merck and Co., Inc., and F. Hoffmann-La Roche, Amgen, Inc., Celgene Corporation and others are also provided in the report.

KEY MARKET BENEFITS:

  • A comprehensive analysis helps to identify the key market trends and dynamics in the Global Melanoma Therapeutics market
  • The studies evaluating competitive landscape and value chain has been taken into account in this report to help in understanding the competitive environment across the geographies
  • The melanoma therapeutics market scenario is comprehensively analyzed in accordance with the key regions
  • Extensive research is done for the market by therapy type which instils a clear understanding regarding the currently used targeted therapy drugs and evolving role of novel therapies
  • The report covers the detailed quantitative analysis of the current market and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
  • Owing to an emerging pipeline in the prostate cancer market, clinical studies have also been taken into account to better understand the market potential and opportunities
  • Competitive intelligence highlights the business practises followed by leading market players across geographies
  • A detailed SWOT analysis enables to study the internal environment of the leading companies for strategy formulation

KEY MARKET SEGMENTS:

The Global Melanoma Therapeutics market segmentation is illustrated below:

Melanoma Therapeutics Market By Therapy Type

  • Chemotherapy
  • Biologic therapy
  • Targeted therapy
  • Radiation therapy
  • Surgery
  • Other novel therapies (Virus based, Adjuvant therapy etc.)

Melanoma Therapeutics Market By Stages

  • Stage 0 (Melanoma in Situ)
  • Stage I
  • Stage II
  • Stage III
  • Stage IV

Melanoma Therapeutics Market By Geography

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • U.K
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • Australia
    • Rest of Asia
  • LAMEA
    • Latin America
    • Middle East and Africa
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
World Melanoma Therapeutics Market- Opportunities and Forecasts, 2014 - 2022

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4833
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5805
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $8096
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo